Company Number: 13828556

Analysis Date: 2025-07-29 14:04 UTC

1. Credit Opinion: DECLINE
   Gofal Cymunedol Ltd is a newly incorporated small private limited company with minimal financial activity, as evidenced by its dormant status and consistent reporting of only £100 in cash and net assets over multiple years. The absence of trading activity, revenues, or operating profits indicates no current capacity to service debt or credit facilities. The company’s financial position shows no growth or operational scale, raising concerns about its ability to generate cash flow or withstand economic fluctuations. Although the directors include a Chartered Accountant and a management consultant, the lack of substantive financial data limits confidence in management’s ability to develop the business or manage credit risk effectively at this stage.

2. Financial Strength:
   The balance sheet is extremely limited, reporting current assets (cash) of only £100 and equal shareholders’ funds, with no liabilities or fixed assets disclosed. The accounts confirm the company was dormant throughout the last two financial years, implying no transactions or operational activities. This very weak asset base and lack of working capital or tangible assets mean the company has negligible financial strength. There is no retained earnings or reserves to support credit exposure.

3. Cash Flow Assessment:
   With reported cash of only £100 and no income or expenses recorded, there is no evidence of positive cash flow generation or working capital. The company’s dormant status means no operational cash inflows exist, and liquidity is effectively non-existent. Without ongoing trading, the company cannot currently meet any debt service obligations or fund business activities from internal resources.

4. Monitoring Points:

• Future trading activity and revenues: Watch for evidence of business commencement and revenue growth.
• Updated financial statements: Monitor for filing of accounts showing operational results and improved asset base.
• Director changes or new PSCs: Changes in ownership or management could indicate strategic shifts.
• Cash flow and liquidity trends: Essential to assess once trading begins.
• Payment history on any granted credit facilities if approved under conditions.